Telemedicine for medical abortion: a systematic review.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
08 2019
Historique:
accepted: 04 03 2019
pubmed: 15 3 2019
medline: 14 8 2019
entrez: 15 3 2019
Statut: ppublish

Résumé

Telemedicine is increasingly being used to access abortion services. To assess the success rate, safety, and acceptability for women and providers of medical abortion using telemedicine. We searched PubMed, EMBASE, ClinicalTrials.gov, and Web of Science up until 10 November 2017. We selected studies where telemedicine was used for comprehensive medical abortion services, i.e. assessment/counselling, treatment, and follow up, reporting on success rate (continuing pregnancy, complete abortion, and surgical evacuation), safety (rate of blood transfusion and hospitalisation) or acceptability (satisfaction, dissatisfaction, and recommendation of the service). Quantitative outcomes were summarised as a range of median rates. Qualitative data were summarised in a narrative synthesis. Rates relevant to success rate, safety, and acceptability outcomes for women ≤10 Based on a synthesis of mainly self-reported data, medical abortion through telemedicine seems to be highly acceptable to women and providers, success rate and safety outcomes are similar to those reported in literature for in-person abortion care, and surgical evacuation rates are higher. A systematic review of medical abortion through telemedicine shows outcome rates similar to in-person care.

Sections du résumé

BACKGROUND
Telemedicine is increasingly being used to access abortion services.
OBJECTIVE
To assess the success rate, safety, and acceptability for women and providers of medical abortion using telemedicine.
SEARCH STRATEGY
We searched PubMed, EMBASE, ClinicalTrials.gov, and Web of Science up until 10 November 2017.
STUDY CRITERIA
We selected studies where telemedicine was used for comprehensive medical abortion services, i.e. assessment/counselling, treatment, and follow up, reporting on success rate (continuing pregnancy, complete abortion, and surgical evacuation), safety (rate of blood transfusion and hospitalisation) or acceptability (satisfaction, dissatisfaction, and recommendation of the service).
DATA COLLECTION AND ANALYSIS
Quantitative outcomes were summarised as a range of median rates. Qualitative data were summarised in a narrative synthesis.
MAIN RESULTS
Rates relevant to success rate, safety, and acceptability outcomes for women ≤10
CONCLUSION
Based on a synthesis of mainly self-reported data, medical abortion through telemedicine seems to be highly acceptable to women and providers, success rate and safety outcomes are similar to those reported in literature for in-person abortion care, and surgical evacuation rates are higher.
TWEETABLE ABSTRACT
A systematic review of medical abortion through telemedicine shows outcome rates similar to in-person care.

Identifiants

pubmed: 30869829
doi: 10.1111/1471-0528.15684
pmc: PMC7496179
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1094-1102

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Swedish Foundation for Medical Research
Pays : International
Organisme : Swedish Society for Medical Research
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 World Health Organization; licensed by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.

Références

Reprod Health. 2017 Aug 22;14(1):100
pubmed: 28830534
MMWR Surveill Summ. 2016 Nov 25;65(12):1-44
pubmed: 27880751
Obstet Gynecol Int. 2014;2014:913241
pubmed: 24693291
Lancet. 2016 Jul 16;388(10041):258-67
pubmed: 27179755
Contraception. 2017 May;95(5):477-484
pubmed: 28232129
Reprod Health Matters. 2010 Nov;18(36):90-101
pubmed: 21111353
Obstet Gynecol. 2015 Jan;125(1):175-83
pubmed: 25560122
BJOG. 2007 May;114(5):569-75
pubmed: 17439565
Contraception. 2014 Feb;89(2):129-33
pubmed: 24314910
Contraception. 2015 Nov;92(5):475-81
pubmed: 26265443
J Fam Plann Reprod Health Care. 2015 Jul;41(3):170-80
pubmed: 26106103
Cochrane Database Syst Rev. 2011 Nov 09;(11):CD002855
pubmed: 22071804
Obstet Gynecol. 2017 Oct;130(4):778-782
pubmed: 28885427
Contraception. 2013 Jan;87(1):26-37
pubmed: 22898359
Contraception. 2011 Jan;83(1):30-3
pubmed: 21134500
Reprod Health Matters. 2015 May;23(45):47-57
pubmed: 26278832
Br J Obstet Gynaecol. 1997 Jul;104(7):829-33
pubmed: 9236649
Gac Sanit. 2015 May-Jun;29(3):198-204
pubmed: 25770915
Lancet. 2017 Nov 25;390(10110):2372-2381
pubmed: 28964589
Contraception. 2017 May;95(5):470-476
pubmed: 28131650
Contraception. 2016 Nov;94(5):489-495
pubmed: 27373541
Contraception. 2014 May;89(5):440-5
pubmed: 24560481
Contraception. 2016 Aug;94(2):122-6
pubmed: 27101901
Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
Implement Sci. 2018 Jan 25;13(Suppl 1):9
pubmed: 29384078
BJOG. 2019 Aug;126(9):1094-1102
pubmed: 30869829
Cochrane Database Syst Rev. 2011 Jan 19;(1):CD005216
pubmed: 21249669
Reprod Health Matters. 2015 Feb;22(44 Suppl 1):83-93
pubmed: 25702072
Am J Public Health. 2016 Nov;106(11):2071-2075
pubmed: 27631756
J Fam Plann Reprod Health Care. 2016 Jan;42(1):77-8
pubmed: 26475329
Bull World Health Organ. 2011 May 1;89(5):360-70
pubmed: 21556304
BJOG. 2017 Jul;124(8):1208-1215
pubmed: 27748001
BJOG. 2008 Aug;115(9):1171-5; discussion 1175-8
pubmed: 18637010
Lancet. 2014 Sep 13;384(9947):980-1004
pubmed: 24797575
Aust N Z J Obstet Gynaecol. 2018 Jun;58(3):335-340
pubmed: 29603139
Cochrane Database Syst Rev. 2015 Jun 26;(6):CD011159
pubmed: 26115146
Eur J Contracept Reprod Health Care. 2017 Oct;22(5):360-362
pubmed: 29164948
Acta Obstet Gynecol Scand. 2012 Feb;91(2):226-31
pubmed: 21950492
Obstet Gynecol. 2015 Jul;126(1):12-21
pubmed: 26241251
Womens Health Issues. 2013 Mar-Apr;23(2):e117-22
pubmed: 23410620
Contraception. 2014 Nov;90(5):480-7
pubmed: 25152258
Contraception. 2017 May;95(5):437-441
pubmed: 28065833
Lancet. 2006 Apr 1;367(9516):1066-1074
pubmed: 16581405
Obstet Gynecol. 2011 Aug;118(2 Pt 1):296-303
pubmed: 21775845
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Int J Gynaecol Obstet. 2014 Feb;124(2):177-8
pubmed: 24332519
J Fam Plann Reprod Health Care. 2006 Jan;32(1):19-22
pubmed: 16492328
J Telemed Telecare. 2017 Aug;23(7):680-685
pubmed: 27418557
J Obstet Gynaecol Res. 2018 Sep;44(9):1705-1711
pubmed: 29974571
BMJ. 2017 May 16;357:j2011
pubmed: 28512085

Auteurs

M Endler (M)

Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.
Department of Public Health, Women's Health Research Unit, University of Cape Town, Cape Town, South Africa.

A Lavelanet (A)

Department of Reproductive Health and Research, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.

A Cleeve (A)

Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.

B Ganatra (B)

Department of Reproductive Health and Research, UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.

R Gomperts (R)

Women on Web, Amsterdam, the Netherlands.

K Gemzell-Danielsson (K)

Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH